Form 4: VolitionRx Officer's Routine Tax Withholding

VolitionRx General Counsel Nicholas Plummer reported a disposition of shares to cover tax obligations from restricted stock unit settlement.

Summary

• Nicholas Plummer, General Counsel of Volition Diagnostics and an officer of VolitionRx Ltd. (VNRX), reported a disposition of 5,647 shares of common stock.
• The transaction occurred on February 1, 2026, at a price of $0.285 per share.
• These shares were retained by VolitionRx for cancellation to satisfy tax withholding obligations related to the settlement of 12,015 restricted stock units (RSUs).
• The RSUs were awarded to Mr. Plummer in lieu of cash compensation.
• No shares were sold by Mr. Plummer or VolitionRx in this transaction.
• Following this reported transaction, Mr. Plummer beneficially owns 233,137 shares of VolitionRx common stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this filing as neutral. It represents a standard, non-discretionary transaction for tax withholding related to equity compensation and does not reflect a change in company fundamentals or insider sentiment.

Future Outlook

This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future performance or strategic direction.

Industry Context

StockSavvy.ai notes that Form 4 filings detailing the disposition of shares for tax withholding purposes are routine occurrences for executives receiving equity compensation. These transactions are typically non-discretionary and are a standard part of managing restricted stock unit vesting.

Stakeholder Impact

• Shareholders: Minimal direct impact as this is a routine, non-discretionary transaction for tax purposes and does not reflect a change in company performance or insider confidence.
• Employees: No direct impact mentioned.

Key Dates

Recommendation

This Form 4 filing details a routine, non-discretionary transaction by an insider to cover tax obligations arising from the vesting of restricted stock units. Such transactions are common and do not typically signal a change in the company's fundamental outlook or the insider's long-term view. Therefore, a 'hold' recommendation is appropriate as this specific event does not provide new information to alter an existing investment thesis.

Keywords

VNRX, VolitionRx, Form 4, insider transaction, tax withholding, restricted stock units, equity compensation, officer